Central nervous system lesions due to juvenile myelomonocytic leukemia progressed in a boy undergoing first line chemotherapy.

Fukushima, Hiroko; Fukushima, Takashi; Hiraki, Akiyoshi; Suzuki, Ryoko; Mahmoud, Shaza S A; Yoshimi, Ai; Nakao, Tomohei; Kato, Keisuke; Kobayashi, Chie; Koike, Kazutoshi; Fukasawa, Masakatsu; Morishita, Yukio; Doisaki, Sayoko; Muramatsu, Hideki; Sumazaki, Ryo

Fukushima, Hiroko; Fukushima, Takashi; Hiraki, Akiyoshi; Suzuki, Ryoko; Mahmoud, Shaza S A; Yoshimi, Ai; Nakao, Tomohei; Kato, Keisuke; Kobayashi, Chie; Koike, Kazutoshi; Fukasawa, Masakatsu; Morishita, Yukio; Doisaki, Sayoko; Muramatsu, Hideki; Sumazaki, Ryo.

Affiliation

Fukushima H; Department of Pediatrics, Tsukuba University Hospital, Tsukuba, Japan. fukushima-tuk@umin.ac.jp

Int J Hematol ; 95(5): 581-4, 2012 May.

Article in En | MEDLINE | ID: mdl-22461033

Subject(s)

Antimetabolites, Antineoplastic/adverse effects; Brain/drug effects; Brain/pathology; Cytarabine/adverse effects; Leukemia, Myelomonocytic, Juvenile/drug therapy; Mercaptopurine/adverse effects; Humans; Infant; Leukemia, Myelomonocytic, Juvenile/pathology; Leukemia, Myelomonocytic, Juvenile/surgery; Male; Stem Cell Transplantation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain / Cytarabine / Leukemia, Myelomonocytic, Juvenile / Mercaptopurine / Antimetabolites, Antineoplastic Limits: Humans / Infant / Male Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2012 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google